$1.25
5.04% yesterday
Nasdaq, Sep 27, 10:00 pm CET
ISIN
CA88338H1001
Symbol
THTX
Sector
Industry

Theratechnologies Inc. Stock price

$1.25
-0.05 3.85% 1M
-0.21 14.38% 6M
-0.37 22.84% YTD
-0.90 41.86% 1Y
-14.43 92.03% 3Y
-15.55 92.56% 5Y
-0.71 36.22% 10Y
Nasdaq, Closing price Fri, Sep 27 2024
+0.06 5.04%
ISIN
CA88338H1001
Symbol
THTX
Sector
Industry

Key metrics

Market capitalization $28.80m
Enterprise Value $52.09m
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF negative
EV/Sales (TTM) EV/Sales 0.63
P/S ratio (TTM) P/S ratio 0.35
P/B ratio (TTM) P/B ratio negative
Revenue growth (TTM) Revenue growth 3.62%
Revenue (TTM) Revenue $82.57m
EBIT (operating result TTM) EBIT $6.33m
Free Cash Flow (TTM) Free Cash Flow $-900.00k
Cash position $36.03m
EPS (TTM) EPS $-0.19
P/E forward negative
P/S forward 0.34
EV/Sales forward 0.62
Short interest 0.03%
Show more

Is Theratechnologies Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,901 stocks worldwide.

Theratechnologies Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

4 Analysts have issued a Theratechnologies Inc. forecast:

3x Buy
75%
1x Hold
25%

Analyst Opinions

4 Analysts have issued a Theratechnologies Inc. forecast:

Buy
75%
Hold
25%

Financial data from Theratechnologies Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
May '24
+/-
%
83 83
4% 4%
100%
- Direct Costs 22 22
9% 9%
27%
60 60
9% 9%
73%
- Selling and Administrative Expenses 32 32
16% 16%
39%
- Research and Development Expense 19 19
51% 51%
22%
9.55 9.55
145% 145%
12%
- Depreciation and Amortization 3.22 3.22
12% 12%
4%
EBIT (Operating Income) EBIT 6.33 6.33
125% 125%
8%
Net Profit -7 -7
81% 81%
-8%

In millions USD.

Don't miss a Thing! We will send you all news about Theratechnologies Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Theratechnologies Inc. Stock News

Neutral
GlobeNewsWire
one day ago
MONTREAL, Sept. 26, 2024 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company focused on the development and commercialization of innovative therapies, today announced the Company will report financial results and provide a business update for its third quarter ended August 31, 2024, on Thursday, October 10 at 8:...
Neutral
GlobeNewsWire
10 days ago
MONTREAL, Sept. 17, 2024 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company focused on the development and commercialization of innovative therapies, today announced a risk of a temporary supply disruption for EGRIFTA SV ® (tesamorelin for injection) in early 2025 caused by an unexpected voluntary shutdown of t...
Neutral
GlobeNewsWire
19 days ago
MONTREAL, Sept. 09, 2024 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company focused on the development and commercialization of innovative therapies, today announced that the Company's President and CEO, Paul Lévesque will be presenting at two investor conferences in September. Members of the Theratechnologies ...
More Theratechnologies Inc. News

Company Profile

Theratechnologies, Inc. is a pharmaceutical company. It engages in addressing medical needs of patients with Human Immunodeficiency Virus (HIV). The firm offers its product under the brand name of EGRIFTA, which approved therapy for the reduction of excess abdominal fat in HIV-infected patients with lipodystrophy. Theratechnologies was founded on October 19, 1993 and is headquartered in Montreal, Canada.

Head office Canada
CEO Paul Lévesque
Employees 114
Founded 1993
Website www.theratech.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today